Try our Advanced Search for more refined results
Securities
-
January 16, 2026
SEC Fines Adviser Over Black Rifle Coffee SPAC Deal Conflict
Engaged Capital LLC was fined $200,000 by the U.S. Securities and Exchange Commission and agreed to a censure Friday over allegations the investment adviser failed to disclose conflicts of interest related to a special purpose acquisition company merger with Black Rifle Coffee Co. in 2022.
-
January 16, 2026
OCC's Gould Takes Aim At Resolution Planning 'Industry'
A top federal regulator called Friday for a sweeping rethink of rules intended to ensure big, complex banks can be safely wound down in a crisis, including potentially ending requirements to file so-called living wills with the Federal Deposit Insurance Corp.
-
January 16, 2026
Stock Buyback Ban Could Shrink Defense Industrial Base
The Trump administration's move to bar defense contractors from buying back their stock or paying shareholder dividends if they are underperforming on their contracts could make companies reconsider working with the U.S. government and counteract the administration's stated goals.
-
January 16, 2026
SEC Secures $39M Orders Wrapping Fla. Investor Fraud Suit
The U.S. Securities and Exchange Commission has gotten final judgments totaling nearly $39 million to wrap up claims that a Florida hedge fund manager, associated entities and their owner defrauded would-be investors by concealing self-dealing and misappropriation.
-
January 16, 2026
SEC Fines Biopharma Co. Execs Over Hidden FDA Findings
Former executives of Spero Therapeutics will pay over $187,000 to settle the U.S. Securities and Exchange Commission's claims they downplayed the likelihood that the U.S. Food and Drug Administration would reject the biopharmaceutical company's new drug application in 2022, the commission said on Friday.
-
January 16, 2026
SEC Fines 'Cash Flow King' Podcaster $3M For Ponzi Scheme
A podcast host dubbed the "Cash Flow King" will pay $3.3 million to settle claims that he ran a multiyear Ponzi scheme that cheated investors out of $11 million through bogus real estate investments, the U.S. Securities and Exchange Commission announced Friday.
-
January 16, 2026
Lifecore Investors Ink $3.8M Deal In Accounting Controls Suit
Biotech company Lifecore Biomedical Inc. has reached a $3.8 million deal with its investors to end their claims the company had weak controls over its financial reporting, impairing its ability to remain compliant with Nasdaq listing requirements and causing share declines.
-
January 16, 2026
6th Circ. Revives Biomed Co. Investor's Suit Over Stock Sale
The Sixth Circuit has ruled that a man who sold his stock in a biomedical research company just before being told the company planned to pursue private equity financing can bring his breach of contract and fiduciary duty claims, reversing a lower court's ruling granting summary judgment to the biomedical company.
-
January 16, 2026
$29M Deal In Boeing Supplier Fraud Suit Gets Final OK
A New York federal judge on Friday approved a $29 million deal to close out a suit alleging that Spirit AeroSystems Holdings Inc. misled investors by failing to disclose pervasive quality problems and a documented history of supplying its chief customer, The Boeing Co., with defective plane parts.
-
January 16, 2026
SIFMA Presses SEC To Reverse Nasdaq Fee Hike
The Securities Industry and Financial Markets Association is urging the U.S. Securities and Exchange Commission to force Nasdaq and other exchanges to stop collecting new fees that the organization argues were allowed to go live with little detail as to why they were necessary or how they comply with the law and past SEC guidance.
-
January 16, 2026
Acadia Investors Get Initial OK For $179M Settlement
Acadia Healthcare Co. Inc. investors have received the first OK from a Tennessee federal judge for a $179 million settlement in a class action alleging the company misled them about the strength of its U.K. operations.
-
January 16, 2026
Pomerantz To Lead Biohaven Investors' FDA Approval Suit
Pomerantz LLP will lead a proposed class of investors accusing biopharmaceutical company Biohaven Ltd. of overstating the odds that two of its product candidates would receive regulatory approval, a Connecticut judge said Friday.
-
January 16, 2026
Judge Yanks $41M Atty Fee Award In SPAC Merger Suit
A Texas federal judge has rescinded an attorney fee award of over $41 million to Robbins Geller Rudman & Dowd LLP, Labaton Keller Sucharow LLP and Entwistle & Cappucci LLP after the firms became engaged in a dispute over the amount of work done and the allocation of fees, among other things.
-
January 16, 2026
7th Circ. Won't Revive Investment Cos.' VIX-Fix Claims
The Seventh Circuit on Thursday affirmed the dismissal of two investment companies' volatility index manipulation claims against Barclays, Morgan & Stanley Co. and other financial institutions, agreeing with a lower court that one lacked standing and the other missed a statutory deadline.
-
January 16, 2026
High Court Takes Up Intel Workers' Bid To Revive 401(k) Suit
The U.S. Supreme Court agreed Friday to hear Intel workers' challenge to a Ninth Circuit decision backing an end to their proposed class action alleging 401(k) mismanagement, a case that gives the justices a chance to clarify the pleading standards for retirement fund underperformance.
-
January 16, 2026
Insurer Says Other Carrier Owes $23M For Old Policy Claims
Sparta Insurance Co. said the former parent of an insurer it acquired reneged on its contractual obligations to handle and pay claims under policies issued before the acquisition, telling a Massachusetts federal court that it is owed more than $23 million in settlement payments, attorney fees and other costs.
-
January 15, 2026
NCAA Urges Feds, States To Rein In College Sports Wagers
The NCAA has urged a federal regulator to suspend prediction market trades based on college sports until appropriate safeguards are in place and called on state gambling commissions to restrict certain types of wagers, saying it knows they are being manipulated.
-
January 15, 2026
SEC Says Healthcare Exec Misspent $10.6M In Investor Funds
The U.S. Securities and Exchange Commission on Thursday accused a healthcare company CEO of misappropriating over $10 million from investors by falsely claiming the funds would be used to develop cancer screening and treatment technology when in fact they were spent on credit card debt, luxury vehicles and strip club visits.
-
January 15, 2026
Getty Loses 2nd Circ. Bid Over $88M Stock Sale Breach Order
A divided Second Circuit on Thursday upheld a ruling requiring Getty Images to pay out nearly $88 million to investors who said they were blocked from purchasing shares in the company once it became public, finding Getty breached a contract promising the investors those shares.
-
January 15, 2026
Musk Slams SEC's 'Premature' Bid For Twitter Buy-Up Win
The U.S. Securities and Exchange Commission shouldn't be handed an early win on its claims Elon Musk didn't make timely disclosures of his stake in Twitter when the regulator hasn't yet produced discovery in the matter, the tech billionaire has argued.
-
January 15, 2026
Dechert Adds Ex-NYC Deputy Mayor To Co-Lead Trial Practice
Dechert LLP announced Thursday that it has hired veteran trial lawyer Randy Mastro, who previously served as former New York City Mayor Eric Adams' first deputy, as a partner and co-chair of the firm's securities and complex litigation practice.
-
January 15, 2026
Ex-CEO Of COVID Vax Maker Accused Of Insider Trading
New York Attorney General Letitia James on Thursday sued the former CEO of healthcare contractor Emergent BioSolutions Inc., alleging insider trading amid troubles manufacturing a COVID-19 vaccine, while signing a $900,000 settlement with the company over its approval of an executive trading plan.
-
January 15, 2026
Dems Push SEC To Pursue Crypto Case Against Justin Sun
Three House Democrats on Thursday pressed the U.S. Securities and Exchange Commission to reinvigorate its paused enforcement case against Tron founder Justin Sun and address their concerns that the agency's wave of crypto case dismissals coincided with considerable industry donations to President Donald Trump.
-
January 15, 2026
Chancery Tosses Vividion IP Suit Over $2B Bayer Deal
The Delaware Chancery Court on Thursday dismissed a biotech investor's suit accusing the co-founder of Vividion Therapeutics Inc. and others of diverting valuable intellectual property ahead of the company's $2 billion sale to Bayer Corp., finding the alleged misconduct could not have affected the merger price or process under Delaware law.
-
January 15, 2026
Nvidia Sued In Del. For US 'Tax' On Chip Deal With China
Alleging possible company conflicts of interest and unlawful agreements involving the White House and Commerce Department, two NVIDIA Corp. stockholders sued the company late Wednesday for records involving company agreements to pay the U.S. Department of Commerce percentages of high-end graphics processing chip sales to buyers in China.
Expert Analysis
-
The SEC Whistleblower Program A Year Into 2nd Trump Admin
The U.S. Securities and Exchange Commission's whistleblower program continues to operate as designed, but its internal cadence, scrutiny of claims and operational structure reflect a period of recalibration, with precision mattering more than ever, say attorneys Scott Silver and David Chase.
-
Key Crypto Class Action Trends And Rulings In 2025
As the law continued to take shape in the growing area of crypto-assets, this year saw a jump in crypto class action litigation, including noteworthy decisions on motions to compel arbitration and class certification, according to Justin Donoho at Duane Morris.
-
How New SEC Policies Shift Shareholder Proposal Landscape
U.S. Securities and Exchange Commission Chairman Paul Atkins' recent remarks provide a road map for public companies to exclude nonbinding shareholder proposals from proxy materials, which would disrupt the mechanism that has traditionally defined how shareholders and companies engage on governance matters, say attorneys at Gunderson.
-
Series
Knitting Makes Me A Better Lawyer
Stretching my skills as a knitter makes me a better antitrust attorney by challenging me to recalibrate after wrong turns, not rush outcomes, and trust that I can teach myself the skills to tackle new and difficult projects — even when I don’t have a pattern to work from, says Kara Kuritz at V&E.
-
Series
The Biz Court Digest: Welcome To Miami
After nearly 20 years in operation, the Miami Complex Business Litigation Division is a pioneer upon which other jurisdictions in the state have been modeled, adopting many innovations to keep its cases running more efficiently and staffing experienced judges who are accustomed to hearing business disputes, say attorneys at King & Spalding.
-
Identifying And Resolving Conflicts Among Class Members
As the Fifth Circuit's recent decision in Nova Scotia Health Employees' Pension Plan v. McDermott International illustrates, intraclass conflicts can determine the fate of a class action — and such conflicts can be surprisingly difficult to identify, says Andrew Faisman, a clerk at the U.S. District Court for the Southern District of New York.
-
What Law Firm Liability Risks In 2025 Signal For Year To Come
Trends and statistics reveal that law firms of all sizes and practice areas remained attractive litigation targets this year, so firms must take concrete steps to avoid professional liability risks in the year to come, say Douglas Richmond and Andrew Ricke at Lockton Companies.
-
Recent Proposals May Spell Supervision Overhaul For Banks
A slew of rules recently proposed by the federal banking agencies with approaching comment deadlines would rewrite supervision standards to be further tailored to banks' size and activities, while prioritizing financial risks over process, documentation and other nonfinancial risks, say attorneys at Davis Wright.
-
What US Can Learn From Brazil's Securities Arbitration Model
To allay investor concerns about its recent approval of mandatory arbitration clauses in public company registration statements, the U.S. Securities and Exchange Commission should look to Brazil's securities arbitration model, which shows that clear rules and strong institutions can complement the goals of securities regulation, say arbiters at the B3 Arbitration Chamber.
-
AI Evidence Rule Tweaks Encourage Judicial Guardrails
Recent additions to a committee note on proposed Rule of Evidence 707 — governing evidence generated by artificial intelligence — seek to mitigate potential dangers that may arise once machine outputs are introduced at trial, encouraging judges to perform critical gatekeeping functions, say attorneys at Lankler Siffert & Wohl.
-
Series
The Law Firm Merger Diaries: Getting The Message Across
Communications and brand strategy during a law firm merger represent a crucial thread that runs through every stage of a combination and should include clear messaging, leverage modern marketing tools and embrace the chance to evolve, says Ashley Horne at Womble Bond.
-
How Bank-Fintech Partnerships Changed In 2025
The 2025 transition to the Trump administration, augmented by the reversal of Chevron deference in 2024, has resulted in unprecedented shifts, and bank-fintech partnerships are no exception, with key changes affecting a number of areas including charters, regulatory oversight and anti-money laundering, say attorneys at K&L Gates.
-
2 Early Settlement Alternatives In Federal Securities Litigation
Most class actions brought under the federal securities laws are either settled or won by the defendants following a motion to dismiss, but two alternative strategies have the potential to lower discovery costs and allow defendants to obtain judgment without the uncertainty of jury trials on complex matters, says Richard Zelichov at DLA Piper.
-
Opinion
Horizontal Stare Decisis Should Not Be Casually Discarded
Eliminating the so-called law of the circuit doctrine — as recently proposed by a Fifth Circuit judge, echoing Justice Neil Gorsuch’s concurrence in Loper Bright — would undermine public confidence in the judiciary’s independence and create costly uncertainty for litigants, says Lawrence Bluestone at Genova Burns.
-
DC Circ. Decision Reaffirms SEC Authority Post-Loper Bright
The recent denial of a challenge to invalidate 2024 amendments to the U.S. Securities and Exchange Commission's tick size and fee-cap rules reinforces the D.C. Circuit's deference to SEC expertise in market structure regulation, even after Loper Bright, though implementation of the rules remains uncertain, say attorneys at Sidley.